Herein, our aims are to investigate the profile of HE4 expression in tissue, serum, urine and cells of ovarian cancer and the effects of HE4 knockdown on malignant biological behaviors of cells as well as its molecular mechanisms. The gene discussed is WFDC2; the disease is ovarian carcinoma.